共 61 条
Molybdenum Trioxide Nanocubes Aligned on a Graphene Oxide Substrate for the Detection of Norovirus by Surface-Enhanced Raman Scattering
被引:40
作者:
Achadu, Ojodomo J.
[1
]
Abe, Fuyuki
[2
]
Suzuki, Tetsuro
[3
]
Park, Enoch Y.
[1
,4
]
机构:
[1] Shizuoka Univ, Res Inst Green Sci & Technol, Shizuoka 4228529, Japan
[2] Shizuoka Inst Environm & Hyg, Dept Microbiol, Fujieda, Shizuoka 4260083, Japan
[3] Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka 4313192, Japan
[4] Shizuoka Univ, Grad Sch Sci & Technol, Dept Biosci, Lab Biotechnol, Shizuoka 4228529, Japan
基金:
日本学术振兴会;
关键词:
molybdenum nanocubes;
single-layer graphene oxide;
dual SERS nanotag/substrate;
SERS-based immunoassay;
norovirus;
immunomagnetic separation;
IN-SITU SYNTHESIS;
GOLD NANOPARTICLES;
QUANTUM DOTS;
SERS;
IMMUNOASSAY;
ANTIGEN;
METAL;
COMBINATION;
DESIGN;
PROBES;
D O I:
10.1021/acsami.0c14729
中图分类号:
TB3 [工程材料学];
学科分类号:
0805 ;
080502 ;
摘要:
A novel biosensing system based on graphene-mediated surface-enhanced Raman scattering (G-SERS) using plasmonic/magnetic molybdenum trioxide nanocubes (mag-MoO3 NCs) has been designed to detect norovirus (NoV) via a dual SERS nanotag/substrate platform. A novel magnetic derivative of MoO3 NCs served as the SERS nanotag and the immunomagnetic separation material of the biosensor. Single-layer graphene oxide (SLGO) was adopted as the 2D SERS substrate/capture platform and acted as the signal reporter, with the ability to accommodate an additional Raman molecule as a coreporter. The developed SERS-based immunoassay achieved a signal amplification of up to similar to 10(9)-fold resulting from the combined electromagnetic and chemical mechanisms of the dual SERS nanotag/substrate system. The developed biosensor was employed for the detection of NoV in human fecal samples collected from infected patients by capturing the virus with the aid of NoV-specific antibody-functionalized magnetic MoO3 NCs. This approach enabled rapid signal amplification for NoV detection with this biosensing technology. The biosensor was tested and optimized using NoV-like particles within a broad linear range from 10 fg/mL to 100 ng/mL and a limit of detection (LOD) of similar to 5.2 fg/mL. The practical applicability of the developed biosensor to detect clinical NoV subtypes in human fecal samples was demonstrated by effective detection with an LOD of similar to 60 RNA copies/mL, which is similar to 10(3)-fold lower than that of a commercial enzyme-linked immunosorbent assay kit for NoV.
引用
收藏
页码:43522 / 43534
页数:13
相关论文